Related Experiment Video
Updated: Feb 3, 2026

A Novel Model of Mild Traumatic Brain Injury for Juvenile Rats
Published on: December 8, 2014
Fashionably Late: A Case of Delayed Cutaneous Manifestations in Juvenile Dermatomyositis
Maya Antoine1, Patrick T Reeves1, Luis Rohena1,2,3
1Department of Pediatrics, San Antonio Uniformed Services Health Education Consortium, San Antonio, TX, USA.
Insights
Juvenile dermatomyositis (JDM) diagnosis can be delayed in children with atypical presentations. Early recognition and revised diagnostic criteria are crucial for better outcomes in this rare inflammatory myopathy.
Area of Science:
- Pediatric Rheumatology
- Dermatology
- Rare Diseases
Background:
- Juvenile dermatomyositis (JDM) is a rare inflammatory myopathy in children, characterized by muscle weakness and skin lesions.
- The 1975 Bohan and Peter criteria are the primary diagnostic tool, relying on specific skin manifestations and lab findings.
Observation:
- A case of a toddler with atypical JDM is presented, where delayed skin lesions (heliotrope and malar rash) hindered initial diagnosis.
- The patient experienced prolonged symptoms, requiring extensive investigations including swallow studies, electromyography, and muscle biopsy for diagnosis.
- Dermatologic manifestations appeared 11 months after the initial presentation of muscle weakness and pain.
Findings:
- Atypical JDM presentations, particularly with delayed dermatologic signs, challenge the current diagnostic criteria.
- The reliance on muscle biopsy and heterogeneous serological markers can contribute to diagnostic delays.
Implications:
- Current diagnostic criteria for JDM may need revision to accommodate atypical presentations.
- Further research into more sensitive and specific diagnostic markers is essential for early JDM detection.
- Timely diagnosis of JDM is critical for reducing morbidity and mortality in affected children.
Abstract:
Juvenile dermatomyositis (JDM) is a rare, but well recognized multi-systemic inflammatory myopathy in children defined by proximal muscle weakness and distinctive skin lesions, that if recognized and treated early result in decreased morbidity and mortality. The 1975 criteria established by Bohan and Peter center around the propensity for early development of heliotrope and Gottron's lesions in combination with specific laboratory abnormalities, and are still the leading diagnostic tool. The following case demonstrates a toddler with an atypical presentation of JDM in which delayed dermatologic manifestations hindered initial diagnosis. A previously healthy 2 years and 11 months old female presented to the emergency department with a 7-month history of bilateral knee pain and progressive muscular weakness. Initial evaluation yielded a diagnosis of idiopathic rhabdomyolysis but progressive deterioration prompted additional workup. During her course of care, the patient required admission at numerous facilities for specialty procedures including swallow studies, electromyography, Nissen fundoplication with G-tube insertion, and eventual muscle biopsy, resulting in pathology clinching the diagnosis. Post-diagnosis the development of a heliotrope and malar rash ensued, 11 months after commencement of original presentation. As the Bohan and Peter criteria of 1975 can help to aid in diagnosis of JDM for textbook presentations, atypical cases such as ours suggest that revision to current diagnostic criteria needs to be established. Also, with many pediatric rheumatologists opting for less invasive methods than muscle biopsy to aid in diagnosis, in combination with the heterogeneous nature of currently tracked serous markers, the risk for delayed or missed diagnosis is amplified. As prior research has demonstrated, early diagnosis leads to better outcomes for children battling JDM. Therefore, it is vital that criteria be revised and additional research be conducted for more sensitive and specific markers to help aid in early diagnosis of JDM.
Related Concept Videos
Acute Pancreatitis II: Clinical Manifestations and Management
Angina III: Clinical Manifestations and Assessment
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Chronic Kidney Disease II: Clinical Manifestations
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:

